Jagsonpal Pharmaceuticals Ltd. - Research Center
507789 JAGSNPHARM Group (B) BSE data
Add to watchlist
| Results | |
| Statement |
Cash flow
|
| More |
Cash flow
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Profit before tax | 34.81 | 27.32 | 21.87 | 9.41 | 9.00 |
| Net cashflow-operating activity | 46.66 | 5.60 | 28.22 | 11.25 | 30.90 |
| Net cash used in investing activity | -57.67 | -26.21 | -2.26 | -10.76 | -0.83 |
| Netcash used in fin. activity | -0.46 | -12.30 | -6.83 | -0.94 | -6.05 |
| Net inc/dec in cash and equivlnt | -11.47 | -32.91 | 19.13 | -0.46 | 24.02 |
| Cash and equivalnt begin of year | 22.53 | 58.94 | 39.81 | 38.53 | 14.51 |
| Cash and equivalnt end of year | 11.05 | 26.03 | 58.94 | 38.07 | 38.53 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis